Delivery Order SPE2DR25D9131-SPE2DR26FCPB7
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on October 3, 2025. The contract, with an ultimate completion date of October 27, 2025, calls for the delivery of Stelara 90 mg/ml syringes to support federal healthcare requirements. This award was issued without a set-aside designation, demonstrating the company's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on June 3, 2025. The delivery order, which carries an ultimate completion date of June 25, 2025, covers the supply of Stelara 90 mg/ml syringes for distribution to military healthcare facilities. This award was issued without a set-aside designation, allowing the vendor to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $81,249.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on October 17, 2025, carries an ultimate completion date of November 7, 2025, and was awarded without a set-aside designation, demonstrating the contractor's competitive capability in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain division on July 11, 2025. The delivery order, issued under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at approximately $390K by the Defense Logistics Agency's Medical Supply Chain for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 23, 2025, is expected to be completed by October 15, 2025, and represents a continuation of the company's substantial role as a critical supplier within the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $97,499.70 by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, carries no set-aside designation and represents one of many pharmaceutical product deliveries issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $243,749.25 for Stelara 90 mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain division on September 8, 2025. This delivery order, with an ultimate completion date of September 29, 2025, carries no set-aside designation and represents a standard procurement action under the company's existing Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,441.36 by the Defense Logistics Agency (DLA) on May 6, 2025. The delivery order, which expires May 28, 2025, covers the supply of Stelara 90 mg/mL syringes to support federal healthcare operations. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open...
- SPE2DR25D9131Indefinite Delivery Contract
- SPE2DR25D9131-SPE2DR26FCPB7Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,168.26 by the Defense Logistics Agency for STELARA 90 mg/mL syringes. The award, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, features a $499,999,999 ceiling value and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. Under this prime vendor contract, DMS Pharmaceutical Group is authorized to supply a full range of pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables to support recurring medical supply needs across the military healthcare system globally. The company's established performance on multiple delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division demonstrates its capability to fulfill specialized pharmaceutical requirements for Department of Defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.2k | 10/23/25 |